...
首页> 外文期刊>Head and neck: Journal for the sciences and specialities of the head and neck >Paranasal sinus tumors: Peter maccallum cancer institute experience.
【24h】

Paranasal sinus tumors: Peter maccallum cancer institute experience.

机译:鼻旁窦肿瘤:彼得马卡勒姆癌症研究所的经验。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND.: The purpose of this study was to evaluate the local control, pattern of recurrence, overall survival, and prognostic factors of patients with squamous cell carcinoma (SCC), adenocarcinoma, and undifferentiated carcinoma of the paranasal sinuses (PNS) and nasal cavity (NC) presenting to our center for curative treatment over a 10-year period. METHODS.: Between 1991 and 2000, 60 patients with SCC (n = 32), adenocarcinoma (n = 25), and undifferentiated carcinoma (n = 3) of the PNS or NC were identified. Forty patients received surgery and postoperative radiotherapy, four surgery alone; 11, radiotherapy alone; three radical radiotherapy after surgical recurrence; one, chemoradiotherapy and surgery; and one, induction chemotherapy followed by radiotherapy. RESULTS.: Forty-seven patients (78%) were seen with T3-4 disease; however, most (92%) were node negative on initial assessment. The predominant failure pattern was local disease persistence or recurrence. The estimated 2- and 5-year local control rates were 63% and 49%, respectively. Orbital and neural invasion significantly affected local control. The estimated 2- and 5 year overall survival rates were 57% and 40%, respectively. CONCLUSIONS.: Local failure remains the dominant cause for poor outcome in this group of patients. Because of the proximity of critical normal structures, the ability to perform adequate surgery and to deliver effective radiotherapy is limited in many cases. The use of postoperative concurrent chemoradiotherapy warrants further investigation.
机译:背景:这项研究的目的是评估鳞状细胞癌(SCC),腺癌,鼻旁窦(PNS)和鼻腔未分化癌患者的局部控制,复发模式,总体生存率和预后因素。 (NC)在我们的中心进行为期10年的治疗。方法:在1991年至2000年之间,确定了60例PNS或NC的SCC(n = 32),腺癌(n = 25)和未分化癌(n = 3)患者。 40例接受手术和术后放疗,仅4例; 11,单独放疗;手术复发后进行三次根治性放疗;一,放化疗和手术;一是诱导化疗,然后放疗。结果:47例患者(78%)被发现患有T3-4疾病;但是,大多数(92%)在初始评估时均为阴性。主要的失败模式是局部疾病持续或复发。估计的2年和5年本地控制率分别为63%和49%。眼眶和神经的侵入显着影响了局部控制。估计的2年和5年总生存率分别为57%和40%。结论:局部衰竭仍然是该组患者预后不良的主要原因。由于关键的正常结构附近,在许多情况下执行适当的手术和进行有效放射治疗的能力受到限制。术后同时放化疗的使用值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号